Member info
Dr Artur Klett
Representative
Estonia
Working Group(s): Anterior Segment Rare Eye Diseases (WG4), National Integration (TWG9)
Team
Dr Kristel Harak
Estonia
Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Registries & Epidemiology (TWG7), Retinal Rare Eye Diseases (WG1)
Dr Katrin Eerme
Estonia
Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)
Dr Reili Rebane
Estonia
CPMS & Digital Medecine (TWG10), Pediatric Ophthalmology Rare Diseases (WG3)
Dr Delis Linntam
Estonia
Anterior Segment Rare Eye Diseases (WG4), Retinal Rare Eye Diseases (WG1)
HCP Center
Internationally recognized experts of East-Tallinn Central Hospital Eye Department treat eye disorders in infants, children and adults.
Picture :...
contact
East-Tallinn Central Hospital Eye Clinic, Tallinn, Estonia
Ravi 18
10138 Tallinn
Estonia
Clinical trials
NCT04423718 Active, Not recruiting
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Interventional
NCT04270747 Completed
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
Interventional
NCT02686658 Completed
A Phase 2/3 Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura™ (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Interventional
Scientific publications
The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement
ERN-EYE promotes access to genetic testing in RED and emphasizes the clinical need and relevance of genetic testing in...